Zantac Lawsuit Attorney
Leifer & Ramirez is currently investigating potential claims for people who have taken Zantac and have been diagnosed with cancer. If you or someone you know has taken Zantac and been diagnosed with cancer, you may be entitled to compensation.
What is Zantac?
Zantac is a popular medication used to treat heartburn and designed to help decrease the amount of acid created by the stomach. Sold both over-the-counter and as a prescription, it is used to decrease the amount of acid in the stomach. Over-the-counter versions are used to treat common conditions such as heartburn and indigestion and prescription options of the product are also available to treat and prevent more severe conditions, such as ulcers and gastroesophageal reflux disease.
Zantac voluntary recall
On Oct. 18, 2019, Sanofi, Zantac’s manufacturer, announced a voluntary recall of its over-the-counter brand-name heartburn drug Zantac due to it containing N-Nitrosodimethylamine (NDMA), which may cause cancer in humans.
FDA Orders Zantac Removed from the Market
On April 1, 2020 the FDA ordered all versions of Zantac to be pulled from the market in the country due to the presence of a carcinogen, NDMA. Laboratory tests indicate that NDMA can cause cancer in humans. The FDA began investigating it and similar toxins in blood pressure and heart failure medications in 2018 and says that it has found “unacceptable levels” of NDMA in some ranitidine products.
Zantac Cancer Lawsuit Investigation
Leifer & Ramirez is investigating potential claims for people who have taken Zantac and have been diagnosed with any of the following types of cancer:
Stomach, Bladder, Kidney, Thyroid, Testicular, Breast, Esophageal, Liver, Colon, Ovarian, Uterine, Prostate, Pancreatic
Contact an attorney
If you or a loved one have been diagnosed with cancer after taking Zantac to treat heartburn you may be entitled to compensation. Call the attorneys at Leifer & Ramirez at (561) 600-1111 or email us today for a free and confidential consultation to discuss your claim.